Phytase: Enzymological Properties, Mechanism of Action, and Applications in Feed and Food
Phytase: Enzymological Properties, Mechanism of Action, and Applications in Feed and Food
Phytase is an enzyme preparation classified as a phosphomonoesterase. It catalyzes stepwise dephosphorylation of myo-inositol hexakisphosphate (phytate; myo-inositol hexakisphosphate, IP6), releasing inorganic phosphate and reducing the strong chelation of minerals such as Ca2+, Zn2+, Fe2+/Fe3+, and Mn2+. As a result, phytase improves the bioavailability of phosphorus and multiple minerals in plant-derived feed and food ingredients. Phytases are widely distributed in animals, plants, and microorganisms and can be found in cereals, legumes, and microbial fermentation products. Based on the initial hydrolysis position, phytases are commonly categorized as myo-inositol hexakisphosphate 3-phosphohydrolases, 6-phosphohydrolases, and related types. With advances in genetic and fermentation engineering, phytase has become a mature commercial enzyme solution in feed production, with a value chain centered on quantifiable outcomes: “available phosphorus release–improved mineral utilization–reduced phosphorus excretion–optimized formulation cost”.
Keywords: phytase; phosphomonoesterase; phytate; myo-inositol hexakisphosphate; available phosphorus; monogastric animals; pelleting stability; solid-state fermentation; submerged fermentation
I. Sources and Types
1.1 Source distribution and biological roles
(1) Plant sources:
Phytase activity can be detected in cereals, legumes, and vegetable tissues, and is especially common in germinating seeds and pollen, consistent with its physiological role in mobilizing stored phosphorus.
(2) Animal sources:
Some animal tissues exhibit phytase-related activity, but industrial feed applications primarily rely on microbial phytase preparations.
(3) Microbial sources:
Diverse phytase-producing microorganisms exist in nature, including bacteria, molds, and fungi, forming the principal resource pool for industrial production and targeted enzyme engineering.
1.2 Type classification and differences in hydrolysis initiation sites
(1) Broad vs narrow definitions
① In a broad sense, enzymes involved in phytate degradation may include phytases and certain phosphatases. Phytase can convert phytate into a series of inositol phosphate esters, but does not necessarily hydrolyze all the way to free myo-inositol and inorganic phosphate under all conditions.
② In a narrow sense, phytase emphasizes specific dephosphorylation activity toward IP6 and should not be treated as equivalent to non-specific phosphatases.
(2) Classification by initial attack position
① myo-Inositol hexakisphosphate 3-phosphohydrolase: preferentially initiates dephosphorylation at the 3-position of IP6.
② myo-Inositol hexakisphosphate 6-phosphohydrolase: preferentially initiates dephosphorylation at the 6-position of IP6.
③ Related non-specific orthophosphomonoesterases: may contribute to dephosphorylation in certain positional contexts (e.g., positions discussed in 2-position-related contexts), depending on the system.
(3) Application implications of type differences:
Differences in initiation site and reaction pathway can affect hydrolysis efficiency under specific pH/ionic conditions, compatibility with different phytate-salt forms in raw materials, and synergy with other enzyme preparations.
II. Mechanism of Action and Reaction Pathways
2.1 Anti-nutritional basis of phytate and chelation behavior
(1) Phytate is a major storage form of phosphorus in plant seeds. Its multiple negatively charged phosphate groups form stable phytate salts with multivalent metal ions.
(2) Chelation reduces mineral bioavailability and can also engage in multi-level interactions with proteins and starch, impacting digestive-enzyme accessibility and nutrient release efficiency.
2.2 Stepwise dephosphorylation catalyzed by phytase
(1) Reaction concept:
Phytase converts IP6 stepwise into IP5, IP4, IP3, IP2, and lower-phosphorylated inositol phosphates while releasing inorganic phosphate.
(2) Pathway schematic:
Phytate → inositol pentakisphosphate (IP5) → inositol tetrakisphosphate (IP4) → inositol trisphosphate (IP3) → inositol bisphosphate (IP2) → inositol monophosphate (IP1) and/or lower products.
(3) Mineral-release mechanism:
As phosphate groups are removed, the chelation capacity of phytate decreases markedly, enabling release of ions such as Ca2+ from complexes and improving mineral absorption accessibility.
2.3 Translating “available phosphorus” release into formulation value
(1) Phytate phosphorus release:
Phytase converts “unavailable or poorly available” phytate phosphorus into more absorbable inorganic phosphorus, reducing the need for supplemental inorganic phosphorus (e.g., dicalcium phosphate).
(2) Improved mineral utilization:
By weakening phytate chelation of Zn, Fe, Mn, Ca, and other minerals, phytase can improve absorption and utilization, enhancing the efficiency of trace-mineral supplementation.
(3) Environmental externalities:
Reduced fecal phosphorus excretion lowers non-point-source pollution pressure from animal production, generating tangible environmental benefits.
III. Feed Industry Applications: Nutrient Replacement, Environmental Benefits, and Process Matching
3.1 Target animals and applicability boundaries
(1) Primary suitability for monogastric animals:
Poultry and swine have limited endogenous phytate-degrading capacity, making phytase supplementation nutritionally and environmentally valuable.
(2) Ruminant context:
Rumen microbiota can produce phytase, so routine supplementation is usually unnecessary; under special formulations or process conditions, the need should be evaluated based on diet structure and evidence.
3.2 Formulation replacement logic: from phytate phosphorus to inorganic phosphorus substitution
(1) Substitution principle:
Determine phytase inclusion based on dietary phytate phosphorus content and calculate the replaceable amount of dicalcium phosphate, while correcting calcium sources (e.g., limestone) to maintain Ca:P balance.
(2) Practical dose-estimation workflow
① Estimate the actual phytate phosphorus content in the diet.
② Set phytase inclusion according to an experience-based rule linking “units of phytase activity per gram of phytate phosphorus”.
③ Calculate the available phosphorus contribution from phytase, determine the replaceable dicalcium phosphate amount, and compensate calcium carried by the replaced phosphate source using limestone or other Ca sources.
(3) Integration into formulation software
① Enter phytase-derived available phosphorus as an “ingredient nutrient value” in the database, set total phosphorus requirements and a maximum enzyme inclusion limit, and allow the system to optimize the formulation.
② If adopting a “full nutrient matrix” approach, also input correction parameters for calcium and trace-mineral availability improvements and calibrate effect sizes using production and animal-trial data.
3.3 Quantifying environmental and economic benefits
(1) Reduced phosphorus excretion:
Improved utilization of phytate phosphorus can substantially decrease fecal phosphorus output; literature and industry summaries often cite a reference range on the order of 40%–60%.
(2) Cost optimization:
When inorganic phosphate prices are high or environmental constraints intensify, phytase can reduce cost by substituting dicalcium phosphate and freeing formulation space.
(3) Drivers of industrial adoption:
Under tightening regulation and raw-material volatility, combined economic and environmental benefits form the core adoption rationale.
3.4 Process matching: grinding, premixing, pelleting, and thermal stability
(1) Heat sensitivity:
Phytase is a protein enzyme and is sensitive to heat and light; conditioning and pelleting temperature, moisture, and residence time can reduce activity.
(2) Pelleting temperature management:
Production commonly applies an upper temperature control (e.g., empirical guidance around not exceeding ~80°C), with the exact window determined by product thermostability grade and process conditions.
(3) Stabilization strategies
① Stabilization treatments reduce pelleting-related activity loss and improve ambient storage stability.
② Coating/encapsulation, thermostable variants, and post-pellet spraying can improve effective enzyme delivery to the animal.
IV. Food and Fermentation Applications
4.1 Phytate degradation and mineral bioaccessibility in foods
(1) Cereal and legume processing:
Phytate degradation improves mineral bioaccessibility and enhances the effectiveness of nutritional fortification.
(2) Texture and structure impacts:
Release of Ca2+ and dissociation of phytate salts can change ionic strength and protein/polysaccharide interactions, affecting texture and processing performance. Structure characterization and texture validation are recommended.
4.2 Functional positioning in fermentation systems
(1) Microbial growth support:
In certain media, phytate presence and its degradation can alter metal availability and redox context, influencing microbial growth and metabolism.
(2) Synergy with lactic acid bacteria and related systems:
Reports suggest that adding phytate or adjusting phytate-salt states can affect growth in lactic-acid-bacteria systems, but practical use should be verified per system and not extrapolated across contexts.
V. Production and Processing Technologies: Strains, Fermentation, and Formulation Engineering
5.1 High-producing strain selection and genetic engineering
(1) Strain selection:
Choosing strains with high productivity, genetic stability, and assessable safety is foundational for cost reduction and lot consistency.
(2) Genetic engineering enabling commercialization:
Since the 1990s, genetic engineering has accelerated phytase commercialization, enabling high activity, improved stability, and scalable production.
5.2 Solid-state vs submerged fermentation routes
(1) Solid-state fermentation:
Suitable for certain strains and processes, potentially yielding specific product forms with some stability advantages.
(2) Submerged fermentation:
Facilitates process control and scale-up and is widely used for industrial production with high-yield strains.
(3) Downstream processing:
Includes separation/purification, concentration, drying, and stabilization. Processing intensity influences impurity profiles, potency retention, and particle morphology.
5.3 Activity levels and product forms
(1) Activity expression:
Commonly reported as units per gram. Unit definitions and assay substrates can differ across companies and standards, so comparisons should be made within the same assay system.
(2) Typical activity levels:
Industry products may reach high unit/g ranges (e.g., technical materials often reference products around the “3000 units/g” level), but actual values should follow the specific product’s validated standard.
(3) Stabilization and shelf stability:
Stabilization determines pelleting loss, storage loss, and shelf life and should be validated via both accelerated stability and real storage-condition testing.
VI. Research and Quality Control: Assays, Key Interferences, and Practical Notes
6.1 Activity assays and methodological consistency
(1) Standardization of substrate and conditions:
Activity values measured under different substrates, pH, and temperature are not directly interchangeable. Research and QC should specify substrate system, reaction time, quench method, and unit definition.
(2) Sample pretreatment:
Feed matrices are complex. Fat, mineral salts, and multi-enzyme backgrounds can interfere with readouts. Apply dilution linearity, spike recovery, and matrix-blank subtraction.
(3) Evaluating retained activity through processing:
Beyond raw potency, quantify residual activity after pelleting and during storage. “Effective activity delivered to the animal” is a more meaningful control metric.
6.2 Managing formulation and process interference factors
(1) Excess dietary calcium:
Overly high Ca levels can reduce phytase efficacy. Avoid excessive limestone inclusion that drives Ca oversupply and weakens enzyme effects.
(2) High heat and strong acids/bases:
High-temperature conditioning and strong acid/alkali environments can inactivate phytase. Avoid direct contact with strong acid/alkali additives and prevent overheating or sun exposure.
(3) Heavy metals and moisture control:
Heavy metals can impair activity or stability; moisture uptake can promote mold and reduce activity. Use moisture-proof packaging, dry storage, and minimize unnecessary storage duration.
6.3 Result validation and calibration via animal trials
(1) Nutritional endpoints:
Use growth performance, bone mineralization, blood phosphorus, and fecal phosphorus output as key endpoints to build an “enzyme activity–available phosphorus–phenotypic benefit” evidence chain.
(2) Cross-ingredient adaptation:
Phytate content and phytate-salt forms vary across raw materials. Build dose–response curves for corn–soy diets, wheat-based diets, and byproduct-rich diets, and calibrate replacement coefficients accordingly.
VII. Aladdin-Related Products
7.1 Phytase and Phytate-Substrate System Related Products
Catalog No. | Product Name | CAS No. | Grade and Purity | Workflow Use | Role in the System |
4-Phytase | 9001-89-2 |
| Enzyme / core reaction component | Catalyzes stepwise dephosphorylation of phytate (IP6), releasing inorganic phosphate and weakening phytate chelation | |
Phytase from Pichia pastoris | 37288-11-2 | technical grade, ≥50 U/mg powder | Enzyme / core reaction component | Microbial phytase activity source for feed/food systems and method development | |
Phytic acid | 83-86-3 | 10mM in Water | Substrate / standard substrate | Canonical IP6 substrate for phytase activity assays, kinetics, and degradation-pathway studies | |
Phytomonic Acid | 503-06-0 | Moligand™, ≥98% | Substrate / high-purity control | High-purity substrate/control for building comparable activity and product-profile datasets | |
Phytic acid dipotassium salt | 129832-03-7 | ≥80% | Substrate (salt form) | Provides “phytate salt” substrate closer to mineral-ion-containing conditions | |
Phytic acid dipotassium salt | 129832-03-7 | 10mM in Water | Substrate (salt form) | Convenient aqueous preparation for activity assays and condition-window scanning | |
Phytic acid sodium salt hydrate | 14306-25-3 | 10mM in Water | Substrate (salt form) | Common aqueous-system substrate for comparing ionic strength/salt-form effects | |
Phytic acid sodium salt hydrate | 14306-25-3 (anhydrous) | ≥90%(dry basis) | Substrate (salt form) | For standardized substrate solutions or salt-form control systems | |
Phytic acid sodium salt hydrate | 14306-25-3 | ≥75% | Substrate (salt form) | For general screening and process/formulation evaluation | |
Phytic acid solution | 83-86-3 | 70% in H2O | Substrate (high-conc. stock) | Enables high-throughput preparation, concentration gradients, and process matching | |
Phytic acid solution | 83-86-3 | 50% in H2O | Substrate (high-conc. stock) | Same purpose for rapid substrate concentration–effect mapping | |
Phytin | 3615-82-5 | Ca: 20.0 ~ 24.0 % | Real-form substrate / chelation control | “Mineral–phytate salt” model to test Ca2+-chelation/precipitation impacts on hydrolysis efficiency | |
Phytic acid hexasodium | 34367-89-0 |
| Real-form substrate / chelation control | Models multi-ion phytate-salt forms to compare salt-form accessibility differences | |
Zinc Phytate | 63903-51-5 | Zn: 27%–34% | Chelation inhibition / mineral release control | Zn2+-chelation model for evaluating Zn release and bioavailability contributions upon phytate degradation |
7.2 Key Reagents Commonly Used for Phytase Activity Assays and Characterization of Phytate Degradation Products
Category | Reagent Name | CAS No. | Workflow Step | Role in the System | Use Notes |
Buffer system | Sodium acetate | pH window (acidic range) | Common acetate buffer covering typical acidic optima for many phytases | Ionic strength can shift substrate solubility/chelation states | |
Buffer system | Acetic acid (glacial) | pH adjustment / buffer prep | Paired with sodium acetate for acetate buffers | Use calibrated pH meter and fixed temperature conditions | |
Buffer system | Citric acid | pH window / chelation background | Builds citrate buffers and can serve as mild chelation-background controls | Citrate chelates metals and can shift mineral-release readouts | |
Buffer system | Trisodium citrate dihydrate | pH window | Paired with citric acid for citrate buffers | Same note: metal-ion effective availability can change | |
Buffer system | Tris | Neutral-to-alkaline testing | Constructs neutral/alkaline conditions to evaluate enzyme-type compatibility | Strong temperature coefficient: fix temperature | |
Buffer system | MES | Neutral buffer (low metal interference) | Stable buffering for biochemical reactions; often “cleaner” for metal-ion readouts | Useful when mineral-release readouts are important | |
Buffer system | MOPS | Neutral buffer | Stabilizes pH and reduces kinetic drift from pH shifts | Fix buffer concentration for comparability | |
pH adjustment | Sodium hydroxide | pH adjustment / start conditions | Rapid pH adjustment or alkaline solution prep | Strong base can inactivate enzymes; avoid enzyme pre-incubation in strong alkali | |
Ionic strength | Sodium chloride | Ionic-strength scanning | Probes effects on substrate solubility/chelation and apparent enzyme activity | Fix total ionic strength together with buffers | |
Metal-ion control | Calcium chloride | Ca2+ background | Models Ca2+ presence in feed/food; evaluates Ca–phytate chelation impacts | Ca2+ readily forms phytate precipitates; monitor turbidity/precipitation | |
Metal-ion control | Zinc sulfate | Zn2+ chelation/release | Builds Zn2+ chelation backgrounds for mineral-release discussions | Watch precipitation/adsorption losses with phosphate/phytate salts | |
Metal-ion control | Ferrous sulfate | Fe2+ chelation/release | Models Fe2+–phytate complexes and release trends after dephosphorylation | Fe2+ oxidizes easily: prepare fresh and control dissolved oxygen | |
Metal-ion control | Ferric chloride | Fe3+ chelation/release | Builds Fe3+ chelation background relevant to some processing/storage contexts | Fe3+ hydrolyzes strongly; use under controlled pH | |
Metal-ion control | Manganese sulfate | Mn2+ background | Evaluates Mn2+ release/chelation relief contributions | Watch coordination/precipitation risks with buffer salts | |
Chelation/control | EDTA | Metal-chelation interference validation | Validates contributions of metal chelation/precipitation to apparent hydrolysis efficiency | Strongly chelates metals; use paired “±EDTA” designs | |
Chelation/control | EGTA | Ca2+-selective chelation control | Helps separate “Ca–phytate salt” contributions | Changes Ca2+ availability and can alter mineral-release readouts | |
Phosphate-release quantitation | Potassium dihydrogen phosphate (KH2PO4) | Inorganic phosphate standard curve | Standard for quantifying released inorganic phosphate | Ensure curve covers sample range; verify dilution linearity | |
Phosphate-release quantitation | Ammonium molybdate | Molybdenum blue/molybdate method | With a reducer, supports colorimetric inorganic phosphate assays | Control reaction time and acidity to reduce within-batch drift | |
Phosphate-release quantitation | Ascorbic acid | Molybdenum blue reducer | Reduces phosphomolybdate complexes to generate colored readouts | Oxidation-prone: prepare fresh, protect from light, keep cold | |
Phosphate-release quantitation | Malachite green | Malachite-green phosphate assay | High-sensitivity inorganic phosphate detection dye | Sensitive to proteins/surfactants; matrix blanks required | |
Phosphate-release quantitation | Poly(vinyl alcohol) (PVA) | Malachite-green stabilizer (optional) | Improves stability and repeatability of malachite-green color development | Effects vary by molecular weight; validate in small-scale tests | |
Substrate/alternative readout | pNPP-Na2 | Non-specific phosphatase control / method dev | General phosphate ester substrate for phosphomonoesterase readout development | Not a phytate substrate; use only as method control, not as IP6 replacement | |
Quench/extraction | Trichloroacetic acid (TCA) | Quench / deproteinization | Rapid quench and protein precipitation to reduce assay interference | Verify compatibility with colorimetry and chromatography | |
Quench/extraction | Acetonitrile | LC sample prep | Protein precipitation and LC-oriented sample handling | Salt co-presence can cause salting-out/phase separation | |
LC support | Formic acid | LC-MS mobile-phase additive | Improves peak shape and ionization for inositol phosphate analyses | Match instrument/column tolerance | |
Analytical standard | myo-Inositol | End-product/background control | Control component for method development; related to dephosphorylation endpoints | Not equivalent to “complete hydrolysis”; interpret with Pi release and IP distribution | |
Analytical support | Sodium bicarbonate | Mild neutralization/buffering | Gentle neutralization of acidified samples | Avoid excessive carbonate that perturbs metal-ion states | |
Matrix-interference control | Polysorbate 20 (Tween 20) | Anti-adsorption/dispersion (optional) | Reduces non-specific adsorption and aggregation in some systems | Surfactants can interfere with colorimetry/malachite-green assays; validate compatibility | |
Matrix-interference control | Polysorbate 80 (Tween 80) | Dispersion/adsorption control (optional) | Similar function in more hydrophobic/complex matrices | Require strict blanks and spike-recovery validation |
Phytase catalyzes stepwise dephosphorylation of phytate, releasing phytate phosphorus and weakening mineral chelation, thereby markedly improving the utilization of phosphorus and multiple minerals in monogastric animal feeds while reducing fecal phosphorus excretion and delivering combined nutritional and environmental benefits. For industrial application, phytate phosphorus content, dietary calcium level, pelleting temperature, and product stabilization should be treated as critical control variables, and integrated management should link “effective retained activity” to “available phosphorus contribution” across both formulation and processing. For research and quality control, activity assay systems should be standardized, and replacement coefficients and dosing windows should be calibrated using animal endpoints to ensure results are reproducible, comparable, and transferable.
